S&P 500   3,161.84 (+0.64%)
DOW   28,102.32 (+0.68%)
QQQ   206.00 (+0.50%)
AAPL   269.56 (-0.45%)
FB   201.85 (-0.20%)
MSFT   152.27 (+0.38%)
GOOGL   1,345.73 (+0.11%)
AMZN   1,756.89 (+0.47%)
CGC   20.47 (+1.09%)
NVDA   220.67 (+1.53%)
MU   50.76 (+3.05%)
GE   11.38 (+3.74%)
TSLA   358.98 (+1.78%)
T   38.40 (+0.60%)
AMD   40.96 (+3.75%)
ACB   2.47 (+0.82%)
F   9.29 (+1.98%)
NFLX   296.26 (-0.89%)
DIS   148.06 (+0.32%)
S&P 500   3,161.84 (+0.64%)
DOW   28,102.32 (+0.68%)
QQQ   206.00 (+0.50%)
AAPL   269.56 (-0.45%)
FB   201.85 (-0.20%)
MSFT   152.27 (+0.38%)
GOOGL   1,345.73 (+0.11%)
AMZN   1,756.89 (+0.47%)
CGC   20.47 (+1.09%)
NVDA   220.67 (+1.53%)
MU   50.76 (+3.05%)
GE   11.38 (+3.74%)
TSLA   358.98 (+1.78%)
T   38.40 (+0.60%)
AMD   40.96 (+3.75%)
ACB   2.47 (+0.82%)
F   9.29 (+1.98%)
NFLX   296.26 (-0.89%)
DIS   148.06 (+0.32%)
S&P 500   3,161.84 (+0.64%)
DOW   28,102.32 (+0.68%)
QQQ   206.00 (+0.50%)
AAPL   269.56 (-0.45%)
FB   201.85 (-0.20%)
MSFT   152.27 (+0.38%)
GOOGL   1,345.73 (+0.11%)
AMZN   1,756.89 (+0.47%)
CGC   20.47 (+1.09%)
NVDA   220.67 (+1.53%)
MU   50.76 (+3.05%)
GE   11.38 (+3.74%)
TSLA   358.98 (+1.78%)
T   38.40 (+0.60%)
AMD   40.96 (+3.75%)
ACB   2.47 (+0.82%)
F   9.29 (+1.98%)
NFLX   296.26 (-0.89%)
DIS   148.06 (+0.32%)
S&P 500   3,161.84 (+0.64%)
DOW   28,102.32 (+0.68%)
QQQ   206.00 (+0.50%)
AAPL   269.56 (-0.45%)
FB   201.85 (-0.20%)
MSFT   152.27 (+0.38%)
GOOGL   1,345.73 (+0.11%)
AMZN   1,756.89 (+0.47%)
CGC   20.47 (+1.09%)
NVDA   220.67 (+1.53%)
MU   50.76 (+3.05%)
GE   11.38 (+3.74%)
TSLA   358.98 (+1.78%)
T   38.40 (+0.60%)
AMD   40.96 (+3.75%)
ACB   2.47 (+0.82%)
F   9.29 (+1.98%)
NFLX   296.26 (-0.89%)
DIS   148.06 (+0.32%)
Log in

NASDAQ:LMNX - Luminex Stock Price, Forecast & News

$21.64
+0.76 (+3.64 %)
(As of 12/12/2019 11:25 AM ET)
Today's Range
$20.99
Now: $21.64
$21.96
50-Day Range
$17.58
MA: $20.37
$21.73
52-Week Range
$17.34
Now: $21.64
$28.33
Volume55,889 shs
Average Volume185,603 shs
Market Capitalization$974.88 million
P/E Ratio45.08
Dividend Yield1.72%
Beta0.82
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; and VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryLife Sciences Tools & Services
SectorMedical
Current SymbolNASDAQ:LMNX
CUSIP55027E10
Phone512-219-8020

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$315.82 million
Cash Flow$1.04 per share
Book Value$10.49 per share

Profitability

Net Income$18.51 million

Miscellaneous

Employees988
Market Cap$974.88 million
Next Earnings Date2/3/2020 (Estimated)
OptionableOptionable

Receive LMNX News and Ratings via Email

Sign-up to receive the latest news and ratings for LMNX and its competitors with MarketBeat's FREE daily newsletter.


Luminex (NASDAQ:LMNX) Frequently Asked Questions

What is Luminex's stock symbol?

Luminex trades on the NASDAQ under the ticker symbol "LMNX."

How often does Luminex pay dividends? What is the dividend yield for Luminex?

Luminex declared a quarterly dividend on Monday, December 9th. Stockholders of record on Thursday, December 19th will be paid a dividend of $0.09 per share on Wednesday, January 15th. This represents a $0.36 dividend on an annualized basis and a dividend yield of 1.66%. The ex-dividend date of this dividend is Wednesday, December 18th. View Luminex's Dividend History.

How were Luminex's earnings last quarter?

Luminex Co. (NASDAQ:LMNX) issued its quarterly earnings data on Monday, November, 4th. The medical instruments supplier reported ($0.12) EPS for the quarter, missing analysts' consensus estimates of ($0.07) by $0.05. The medical instruments supplier had revenue of $78.67 million for the quarter, compared to the consensus estimate of $81.75 million. Luminex had a negative return on equity of 2.38% and a negative net margin of 2.93%. The business's revenue was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.04 EPS. View Luminex's Earnings History.

When is Luminex's next earnings date?

Luminex is scheduled to release their next quarterly earnings announcement on Monday, February 3rd 2020. View Earnings Estimates for Luminex.

What price target have analysts set for LMNX?

3 brokers have issued 1-year price targets for Luminex's shares. Their forecasts range from $21.00 to $32.00. On average, they expect Luminex's share price to reach $26.50 in the next year. This suggests a possible upside of 22.5% from the stock's current price. View Analyst Price Targets for Luminex.

What is the consensus analysts' recommendation for Luminex?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Luminex in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Luminex.

Has Luminex been receiving favorable news coverage?

Headlines about LMNX stock have trended negative recently, InfoTrie reports. The research firm identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Luminex earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave news articles about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Luminex.

Are investors shorting Luminex?

Luminex saw a decline in short interest in the month of November. As of November 15th, there was short interest totalling 866,300 shares, a decline of 9.3% from the October 31st total of 954,700 shares. Based on an average daily volume of 180,500 shares, the days-to-cover ratio is presently 4.8 days. Approximately 2.1% of the company's shares are short sold. View Luminex's Current Options Chain.

Who are some of Luminex's key competitors?

What other stocks do shareholders of Luminex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Luminex investors own include Baidu (BIDU), Micron Technology (MU), Alphabet (GOOG), Starbucks (SBUX), AbbVie (ABBV), Caterpillar (CAT), Johnson & Johnson (JNJ), Nucor (NUE), Schlumberger (SLB) and Verizon Communications (VZ).

Who are Luminex's key executives?

Luminex's management team includes the folowing people:
  • Mr. Nachum Shamir, CEO, Pres & Director (Age 65)
  • Mr. Harriss T. Currie, CFO, Sr. VP of Fin. & Treasurer (Age 57)
  • Mr. Richard W. Rew II, Sr. VP, Gen. Counsel & Corp. Sec. (Age 51)
  • Mr. Todd C. Bennett, Sr. VP of Global Sales & Customer Operations (Age 49)
  • Mr. Randall J. Myers, Sr. VP of Global Manufacturing & Quality (Age 57)

Who are Luminex's major shareholders?

Luminex's stock is owned by many different of retail and institutional investors. Top institutional shareholders include State Street Corp (2.68%), Investment Management of Virginia LLC (2.10%), Millennium Management LLC (0.88%), Hancock Whitney Corp (0.49%), Russell Investments Group Ltd. (0.47%) and Great Lakes Advisors LLC (0.41%). Company insiders that own Luminex stock include Charles J Collins, Eric Shapiro, G Walter Loewenbaum II, Nachum Shamir and Todd C Bennett. View Institutional Ownership Trends for Luminex.

Which institutional investors are selling Luminex stock?

LMNX stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Hussman Strategic Advisors Inc., Russell Investments Group Ltd., Hancock Whitney Corp, State Street Corp, Squarepoint Ops LLC, Barclays PLC and Fisher Asset Management LLC. View Insider Buying and Selling for Luminex.

Which institutional investors are buying Luminex stock?

LMNX stock was purchased by a variety of institutional investors in the last quarter, including Benjamin F. Edwards & Company Inc., Tocqueville Asset Management L.P., Great Lakes Advisors LLC, State of Alaska Department of Revenue, Bridge City Capital LLC, SG Americas Securities LLC, Rhumbline Advisers and California Public Employees Retirement System. Company insiders that have bought Luminex stock in the last two years include G Walter Loewenbaum II and Nachum Shamir. View Insider Buying and Selling for Luminex.

How do I buy shares of Luminex?

Shares of LMNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Luminex's stock price today?

One share of LMNX stock can currently be purchased for approximately $21.64.

How big of a company is Luminex?

Luminex has a market capitalization of $974.88 million and generates $315.82 million in revenue each year. The medical instruments supplier earns $18.51 million in net income (profit) each year or $0.48 on an earnings per share basis. Luminex employs 988 workers across the globe.View Additional Information About Luminex.

What is Luminex's official website?

The official website for Luminex is http://www.luminexcorp.com/.

How can I contact Luminex?

Luminex's mailing address is 12212 TECHNOLOGY BLVD, AUSTIN TX, 78727. The medical instruments supplier can be reached via phone at 512-219-8020 or via email at [email protected]


MarketBeat Community Rating for Luminex (NASDAQ LMNX)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  228 (Vote Outperform)
Underperform Votes:  352 (Vote Underperform)
Total Votes:  580
MarketBeat's community ratings are surveys of what our community members think about Luminex and other stocks. Vote "Outperform" if you believe LMNX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LMNX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/12/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel